The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer
Open accessAbstract
The human intestinal microbiome plays a major role in human health and diseases, including colorectal cancer. Colorectal carcinogenesis represents a heterogeneous process with a differing set of somatic molecular alterations, influenced by diet, environmental and microbial exposures, and host immunity. Fusobacterium species are part of the human oral and intestinal microbiota. Metagenomic analyses have shown an enrichment of Fusobacterium nucleatum (F. nucleatum) in colorectal carcinoma tissue. Using 511 colorectal carcinomas from Japanese patients, we assessed the presence of F. nucleatum. Our results showed that the frequency of F. nucleatum positivity in the Japanese colorectal cancer was 8.6% (44/511), which was lower than that in United States cohort studies (13%). Similar to the United States studies, F. nucleatum positivity in Japanese colorectal cancers was significantly associated with microsatellite instability (MSI)-high status. Regarding the immune response in colorectal cancer, high levels of infiltrating T-cell subsets (i.e., CD3+, CD8+, CD45RO+, and FOXP3+ cells) have been associated with better patient prognosis. There is also evidence to indicate that molecular features of colorectal cancer, especially MSI, influence T-cell-mediated adaptive immunity. Concerning the association between the gut microbiome and immunity, F. nucleatum has been shown to expand myeloid-derived immune cells, which inhibit T-cell proliferation and induce T-cell apoptosis in colorectal cancer. This finding indicates that F. nucleatum possesses immunosuppressive activities by inhibiting human T-cell responses. Certain microRNAs are induced during the macrophage inflammatory response and have the ability to regulate host-cell responses to pathogens. MicroRNA-21 increases the levels of IL-10 and prostaglandin E2, which suppress antitumor T-cell-mediated adaptive immunity through the inhibition of the antigen-presenting capacities of dendritic cells and T-cell proliferation in colorectal cancer cells. Thus, emerging evidence may provide insights for strategies to target microbiota, immune cells and tumor molecular alterations for colorectal cancer prevention and treatment. Further investigation is needed to clarify the association of Fusobacterium with T-cells and microRNA expressions in colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“supporting studies reporting that F nucleatum reduces the anti-tumor immune response.”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [29]
In the citing paper
“Moreover, levels of F nucleatum in tumor tissue have been associated with lower infiltration by T cells,29, 30”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
Snyder, A., Makarov, V., Merghoub, T., Yuan, J., Zaretsky, J. M., Desrichard, A., Walsh, L. A., Postow, M. A., Wong, P., Ho, T. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406498 · Cited by 4,286
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Powles, T. B., Eder, J. P., Fine, G. D., Braiteh, F. S., Loriot, Y., Cruz, C., Joaquim Bellmunt, B., Burris, H. A., Petrylak, D. P., Teng, S.-L. M., et al. (2014) · Nature · doi:10.1038/nature13904 · Cited by 2,410
Treatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,262
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature reviews. Immunology · doi:10.1038/nri1806 · Cited by 2,135
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Landon, M., Saam, J. R., Brown, K. L., Moyes, K., Evans, B. A., & WENSTRUP, R. J. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,943
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R. A., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,851
Wang, D., & DuBois, R. N. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2809 · Cited by 1,794
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Schwabe, R. F., & Jobin, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3610 · Cited by 1,689
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. �., Au, G. K. �., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,591
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Goede, V., Fischer, K., Busch, R. M., Engelke, A., Eichhorst, B. F., Wendtner, C., Chagorova, T., de la Serna, J., Dilhuydy, M., Illmer, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313984 · Cited by 1,530
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,052
Salama, P. R., Phillips, M. R., Grieu, F., Morris, M. J., Zeps, N., Joseph, D. J., Platell, C. F. E., & Iacopetta, B. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 1,025
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005
Clinical relevance of circulating cell-free microRNAs in cancer
Schwarzenbach, H., Nishida, N., Calin, G. A., & Pantel, K. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.5 · Cited by 969
Cytokine patterns in patients with cancer: a systematic review
Lippitz, B. E. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70582-x · Cited by 922
A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P. J., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 861
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S., Colombo, M. P., Ochoa, A. C., Ostrand‐Rosenberg, S., & Schreiber, H. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 834
Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.023 · Cited by 830
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I., Pincus, Z., Barrera, F. N., Liu, C. S., Svoronos, A. A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2014) · Nature · doi:10.1038/nature13905 · Cited by 825
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M. F., Giovannucci, E. L., & Fuchs, C. S. (2008) · Gut · doi:10.1136/gut.2008.155473 · Cited by 772
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 671
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., Kim, S. A., Masuda, A., Nowak, J. A., Nosho, K., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1377 · Cited by 669
Strauss, J., Kaplan, G. G., Beck, P. L., Rioux, K. P., Panaccione, R., DeVinney, R., Lynch, T., & Allen‐Vercoe, E. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21606 · Cited by 578
Tregs and rethinking cancer immunotherapy
Curiel, T. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31202 · Cited by 558
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
Histopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 510
Nosho, K., Baba, Y., Tanaka, N., Shima, K., Hayashi, M., Meyerhardt, J. A., Giovannucci, E., Dranoff, G., Fuchs, C. S., & Ogino, S. (2010) · The Journal of Pathology · doi:10.1002/path.2774 · Cited by 502
Flanagan, L., Schmid, J., Ebert, M., Soucek, P., Kunicka, T., Liska, V., Bruha, J., Neary, P., Dezeeuw, N., Tommasino, M., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2081-3 · Cited by 498
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma
Tahara, T., Yamamoto, E., Suzuki, H., Maruyama, R., Chung, W., Garriga, J., Jelinek, J., Yamano, H.-O., Sugai, T., An, B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1865 · Cited by 465
Ogino, S., Nosho, K., Irahara, N., Meyerhardt, J. A., Baba, Y., Shima, K., Glickman, J. N., Ferrone, C. R., Mino-Kenudson, M. A., Tanaka, N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1438 · Cited by 418
Michaud, D. S., Izard, J., Wilhelm-Benartzi, C. S., You, D.-H., Grote, V. A., Tjønneland, A. M., Dahm, C. C., Overvad, K., Jenab, M., Fedirko, V., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-303006 · Cited by 412
Mitsuhashi, K., Nosho, K., Sukawa, Y., Matsunaga, Y., Ito, M., Kurihara, H., Kanno, S., Igarashi, H., Naito, T., Adachi, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3109 · Cited by 404
Schwitalle, Y., Kloor, M., Eiermann, S., Linnebacher, M., Kienle, P., Knaebel, H. P., Tariverdian, M., Benner, A., & Doeberitz, M. V. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.015 · Cited by 386
Jenkins, M. A., Hayashi, S., O’Shea, A.-M., Burgart, L. J., Smyrk, T., Shimizu, D. M., Waring, P. M., Ruszkiewicz, A. R., Pollett, A. F., Redston, M. S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.044 · Cited by 374
Sinicrope, F. A., Rego, R. L., Ansell, S. M., Knutson, K. L., Foster, N. R., & Sargent, D. J. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.053 · Cited by 334
Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001868 · Cited by 333
Fusobacterium nucleatumin Periodontal Health and Disease
Signat, B., Roques, C. G., Poulet, P. P., & Duffaut, D. (2011) · Current Issues in Molecular Biology · doi:10.21775/cimb.013.025 · Cited by 332
Ohkusa, T., Okayasu, I., Ogihara, T., Morita, K., Ogawa, M., & Sato, N. (2002) · Gut · doi:10.1136/gut.52.1.79 · Cited by 300
Control of metastatic progression by microRNA regulatory networks
Pencheva, N., & Tavazoie, S. F. (2013) · Nature Cell Biology · doi:10.1038/ncb2769 · Cited by 299
Cancer immunology—analysis of host and tumor factors for personalized medicine
Ogino, S., Galon, J., Fuchs, C. S., & Dranoff, G. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.122 · Cited by 287
Shia, J., Ellis, N. A., Paty, P. B., Nash, G. M., Qin, J., Offit, K., Zhang, X.-M., Markowitz, A. J., Nafa, K., Guillem, J. G., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200311000-00002 · Cited by 222
Mao, Y., Poschke, I. C., Wennerberg, E., de Coaña, Y. P., Brage, S. E., Schultz, I., Hansson, J., Masucci, G. V., Lundqvist, A., & Kiessling, R. W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4115 · Cited by 192
Wang, P., Zhuang, L., Zhang, J., Fan, J., Luo, J., Chen, H., Wang, K., Liu, L., Chen, Z., & Meng, Z. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.10.011 · Cited by 186
Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes
Kaplan, C. W., Ma, X., Paranjpe, A., Jewett, A., Lux, R., Haake, S. K., & Shi, W. (2010) · Infection and Immunity · doi:10.1128/iai.00567-10 · Cited by 182
Nosho, K., Kure, S., Irahara, N., Shima, K., Baba, Y., Spiegelman, D. L., Meyerhardt, J. A., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.002 · Cited by 173
Use of tumour-responsive T cells as cancer treatment
Disis, M. L., Bernhard, H., & Jaffee, E. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60404-9 · Cited by 167
Role of bacterial infections in pancreatic cancer
Michaud, D. S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt249 · Cited by 154
Tougeron, D., Fauquembergue, É., Rouquette, A., Pessot, F. L., Sesboüé, R., Laurent, M., Berthet, P., Mauillon, J., Fiore, F. D., Sabourin, J., et al. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.80 · Cited by 153
Dong, J., Zhao, Y.-P., Zhou, L., Zhang, T., & Chen, G. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.01.006 · Cited by 150
Nagao, Y., Hisaoka, M., Matsuyama, A., Kanemitsu, S., Hamada, T., Fukuyama, T., Nakano, R., Uchiyama, A., Kawamoto, M., Yamaguchi, K., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.142 · Cited by 116
Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway
Nosho, K., Igarashi, H., Nojima, M., Ito, M., Maruyama, R., Yoshii, S., Naito, T., Sukawa, Y., Mikami, M., Sumioka, W., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt374 · Cited by 112
Sempere, L. F., Preis, M., Yezefski, T., Ouyang, H., Suriawinata, A. A., Silahtaroglu, A., Conejo-Garcia, J. R., Kauppinen, S., Wells, W. A., & Korc, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1152 · Cited by 112
Suppression of human lymphocyte responses by oral spirochetes: a monocyte-dependent phenomenon.
Shenker, B. J., Listgarten, M. A., & Taichman, N. S. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.4.2039 · Cited by 105
Jewett, A., Hume, W. R., Lê, H., Huynh, T. N., Han, Y. W., Cheng, G., & Shi, W. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1893-1898.2000 · Cited by 92
Shenker, B. J., & Datar, S. V. (1995) · Infection and Immunity · doi:10.1128/iai.63.12.4830-4836.1995 · Cited by 91
Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells
Mace, T. A., Collins, A., Wojcik, S. E., Croce, C. M., Lesinski, G. B., & Bloomston, M. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.04.061 · Cited by 90
Ma, M., Kong, X., Weng, M., Cheng, K., Gong, W. J., Quan, Z.-W., & Peng, C. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-71 · Cited by 89
Baba, Y., Nosho, K., Shima, K., Huttenhower, C., Tanaka, N., Hazra, A., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.050 · Cited by 89
MicroRNAs and Toll-like Receptor/Interleukin-1 Receptor Signaling
Virtue, A. T., Wang, H., & Yang, X. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-66 · Cited by 74
Farrell, J. J., Toste, P. A., Wu, N., Li, L., Wong, J. L., Malkhassian, D., Tran, L. M., Wu, X., Li, X., Dawson, D. W., et al. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.167 · Cited by 70
Igarashi, H., Kurihara, H., Mitsuhashi, K., Ito, M., Okuda, H., Kanno, S., Naito, T., Yoshii, S., Takahashi, H., Kusumi, T., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4264-7 · Cited by 63
miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth
Lu, L., Byrnes, K., Han, C. L., Wang, Y., & Wu, T. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0419 · Cited by 63
Liver abscess caused by periodontal bacterial infection with Fusobacterium necrophorum
Yoneda, M., Kato, S., Mawatari, H., Kirikoshi, H., Imajo, K., Fujita, K., Endo, H., Takahashi, H., Inamori, M., Kobayashi, N., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00748.x · Cited by 52
Microbiological Analysis of Pancreatic Abscess
Brook, I., & Frazier, E. H. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.384 · Cited by 51
Ito, M., Mitsuhashi, K., Igarashi, H., Nosho, K., Naito, T., Yoshii, S., Takahashi, H., Fujita, M., Sukawa, Y., Yamamoto, E., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28920 · Cited by 49
Mitsuhashi, K., Yamamoto, I., Kurihara, H., Kanno, S., Ito, M., Igarashi, H., Ishigami, K., Sukawa, Y., Tachibana, M., Takahashi, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4294 · Cited by 43
A microRNA meta-signature for pancreatic ductal adenocarcinoma
Frampton, A. E., Giovannetti, E., Jamieson, N. B., Krell, J., Gall, T., Stebbing, J., Jiao, L. R., & Castellano, L. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.893192 · Cited by 34
Liver Abscesses due to Fusobacterium spp. that Mimick Malignant Metastatic Liver Disease
Athavale, N. V., Leitch, D. G., & Cowling, P. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0844-8 · Cited by 27
Shenker, B. J., & Matt, W. C. (1987) · Immunopharmacology · doi:10.1016/0162-3109(87)90028-2 · Cited by 26
Hansen, T. F., Kjær‐Frifeldt, S., Christensen, R., Morgenthaler, S., Blöndal, T., Lindebjerg, J., Sørensen, F. B., & Jakobsen, A. K. M. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.409 · Cited by 25
O'Callaghan, G. P., Ryan, A. E., Neary, P., O’Mahony, C., Shanahan, F., & Houston, A. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28076 · Cited by 24
Seroprevalence ofFusobacterium variumin ulcerative colitis patients in Japan
Minami, M., Ando, T., Okamoto, A., Sasaki, N., Ohkura, T., Torii, K., Hasegawa, T., Ohta, M., & Goto, H. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00550.x · Cited by 22
Honda, T., Takahashi, N., Miyauchi, S., & Yamazaki, K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.102 · Cited by 22
The Role of Aggregation in Fusobacterium nucleatum– induced Immune Cell Death
Huynh, T. N., Kapur, R. V., Kaplan, C. W., Cacalano, N. A., Haake, S. K., Shi, W., Sieling, P. A., & Jewett, A. (2011) · Journal of Endodontics · doi:10.1016/j.joen.2011.06.034 · Cited by 22
Haake, S. K., & Lindemann, R. A. (1997) · Journal of Periodontology · doi:10.1902/jop.1997.68.1.39 · Cited by 21
Fusobacterium necrophorum – beyond Lemierres syndrome: Figure 1
Shahani, L., & Khardori, N. M. (2011) · BMJ Case Reports · doi:10.1136/bcr.07.2011.4527 · Cited by 21
Naito, T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.10050 · Cited by 16
Clinicopathological and Molecular Characteristics of Serrated Lesions in Japanese Elderly Patients
Nosho, K., Igarashi, H., Ito, M., Mitsuhashi, K., Kurihara, H., Kanno, S., Yoshii, S., Mikami, M., Takahashi, H., Kusumi, T., et al. (2015) · Digestion · doi:10.1159/000368820 · Cited by 13
Speetjens, F. M., Kuppen, P. J. K., Morreau, H., & van der Burg, S. H. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.040 · Cited by 11
MicroRNA-31 expression in colorectal serrated pathway progression
Aoki, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.12346 · Cited by 8
Flagged first, then by citations
Cited by
Sorted by citations
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez‐de‐Diego, C., Pradilla-Dieste, A., Cerrada, E., & Yoldi, M. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,639
Diet, microorganisms and their metabolites, and colon cancer
O'Keefe, S. J. D. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.165 · Cited by 1,100
Yang, Y. P., Weng, W., Peng, J., Hong, L., Yang, L., Toiyama, Y., Gao, R., Liu, M., Yin, M., Pan, C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.11.018 · Cited by 1,037
The Intestinal Microbiota in Colorectal Cancer.
Tilg, H., Adolph, T. E., Gerner, R. R., & Moschen, A. R. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.004 · Cited by 777
Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer
Song, M., Chan, A. T., & Sun, J. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.048 · Cited by 752
Metadata
- Authors
- Nosho, K.
- Affiliations
- Sapporo Medical University (JP)
- Corresponding author
- Nosho, Katsuhiko
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 22
- Issue
- 2
- Pages
- 557
- ISSN
- 1007-9327 (ISSN-L)
- PMC
- PMC4716059
- OpenAlex
- W2298181742
- Cited by
- 344
- References
- 99
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 34 · 2023: 47 · 2022: 49 · 2021: 46 · 2020: 36 · 2019: 33 · 2018: 36 · 2017: 17 · 2016: 8
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- World Journal of Gastroenterology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pancreas Research Foundation of Japan
- Japan Society for the Promotion of Science (221S0001, 25670371, 26640101)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, gut microbiota, microsatellite instability, antitumor immunity, T cell infiltration, immunosuppression, myeloid-derived cells, miR-21, IL-10, prostaglandin E2, dendritic cells, Japanese patients
- MeSH terms
- Gastrointestinal Microbiome, Animals, Fusobacterium Infections, Humans, Immunity, Innate, Lymphocyte Activation, Biomarkers, Tumor, Colorectal Neoplasms, T-Lymphocyte Subsets, Lymphocytes, Tumor-Infiltrating, Fusobacterium nucleatum, Tumor Escape, Microsatellite Instability, Host-Pathogen Interactions, Adaptive Immunity, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
